
Ann Theodore Sarcoidosis Breakthrough Initiative Grant Program
Overview
The Ann Theodore Foundation partnered with the Science Philanthropy Accelerator for Research and Collaboration (SPARC) in 2020 to better understand the sarcoidosis landscape with the goal of developing philanthropic strategies that could be used to overcome barriers to scientific progress and improve clinical outcomes. The programbrings together all funded researchers for annual meetings, promotes the sharing of research and the development of collaborations across institutions that would otherwise go untapped.
Funded Research
RFP: Ann Theodore Foundation Breakthrough Sarcoidosis Initiative
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the biology and epidemiology of sarcoidosis.

Sarcoidosis Scientific Advisory Board

Catherine Bonham

Erica Herzog

Ogugua Obi
Ann Theodore Sarcoidosis Breakthrough Initiative Grant Program
Related Articles
Request for Proposals: Ann Theodore Foundation Learning Opportunities in Medicine and Sarcoidosis
The ATF-LOMAS is now accepting applications for awards of up to $100,000 per year for two-year research projects led by early career investigators who seek to increase the foundational understanding of sarcoidosis through projects focused...Read ArticleRequest for Proposals: Ann Theodore Foundation Breakthrough Sarcoidosis Initiative
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the...Read ArticleAnn Theodore Foundation Breakthrough Sarcoidosis Initiative Grant Awardees 2023
The Ann Theodore Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding for research to advance understanding of the underlying biology of sarcoidosis, a poorly understood immune...Read ArticleMultimillion-Dollar Scientific Grant Program Releases Third Cycle of Funding to Increase Foundational Understanding of Sarcoidosis
WASHINGTON, DC (September 20, 2023) — The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI), in partnership with the Milken Institute, launched its latest round of funding today.Read ArticleAnn Theodore Foundation Breakthrough Sarcoidosis Initiative Grant Awardees 2022
The Ann Theodore Foundation and the Milken Institute are pleased to announce the six research teams that have been selected to receive funding for their research to advance understanding of the underlying biology of sarcoidosis, a poorly...Read ArticleResearchers Invited to Apply for Funding for Basic Science in Sarcoidosis
The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundation (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an...Read ArticleImageChad Clinton
Director, Media RelationsChad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.Sarcoidosis Case Study
Situation Sarcoidosis is defined by the dramatic accumulation of granulomas—dense clusters of immune cells—in organs throughout the body. Individuals living with sarcoidosis often go undiagnosed for years, enduring symptoms such as...Read ArticleAdvancing Scientific Sarcoidosis Research
Sarcoidosis is a complex, difficult-to-diagnose condition that can present in a variety of ways. It can disappear without symptoms in a couple of years for some people or lead to organ damage and death in others. Current treatment options...Read ArticleType 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population...Read Report